Published in Cytokine on November 20, 2010
The effects of carbohydrate ingestion during endurance running on post-exercise inflammation and hepcidin levels. Eur J Appl Physiol (2011) 0.98
Iron status and the acute post-exercise hepcidin response in athletes. PLoS One (2014) 0.96
Exercise-induced immunodepression in endurance athletes and nutritional intervention with carbohydrate, protein and fat-what is possible, what is not? Nutrients (2012) 0.93
Effects of a 7-day military training exercise on inflammatory biomarkers, serum hepcidin, and iron status. Nutr J (2013) 0.85
Do high blood hepcidin concentrations contribute to low ferritin levels in young tennis players at the end of tournament season? J Sports Sci Med (2013) 0.82
Timing of post-exercise carbohydrate ingestion: influence on IL-6 and hepcidin responses. Eur J Appl Physiol (2015) 0.80
Influence of post-exercise hypoxic exposure on hepcidin response in athletes. Eur J Appl Physiol (2014) 0.78
Carbohydrate Supplementation Influences Serum Cytokines after Exercise under Hypoxic Conditions. Nutrients (2016) 0.75
Normalization of elevated cardiac, kidney, and hemolysis plasma markers within 48 h in Mexican Tarahumara runners following a 78 km race at moderate altitude. Am J Hum Biol (2014) 0.75
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. Clin Infect Dis (2007) 1.17
Efficacy and safety of etravirine (TMC125) in patients with highly resistant HIV-1: primary 24-week analysis. AIDS (2007) 1.01
ARIES 144 week results: durable virologic suppression in HIV-infected patients simplified to unboosted atazanavir/abacavir/lamivudine. HIV Clin Trials (2012) 0.95
Prevalence of allergy and upper respiratory tract symptoms in runners of the London marathon. Med Sci Sports Exerc (2012) 0.93
Similar efficacy of raltegravir when used with or without a protease inhibitor in treatment-experienced patients. HIV Clin Trials (2011) 0.93
Evaluation of efficacy, safety, pharmacokinetics, and adherence in HIV-1-infected, antiretroviral-naïve patients treated with ritonavir-boosted atazanavir plus fixed-dose tenofovir DF/emtricitabine given once daily. HIV Clin Trials (2008) 0.88
Influence of compression garments on recovery after marathon running. J Strength Cond Res (2014) 0.85
Changes in bone mineral density after 96 weeks of treatment with atazanavir/ritonavir or lopinavir/ritonavir plus tenofovir DF/emtricitabine in treatment-naive patients with HIV-1 infection: the CASTLE body composition substudy. J Acquir Immune Defic Syndr (2015) 0.84
The effect of exercise on plasma soluble IL-6 receptor concentration: a dichotomous response. Exerc Immunol Rev (2010) 0.80
Virologic and immunologic activity of PegIntron in HIV disease. AIDS (2009) 0.75